Loading search results

Outcome Measures

Primary Outcomes (1)

Rate of Vaccination for HPV (n of patients with HPV vaccination/n of patients eligible for vaccination)
Vaccination among eligible clinic patients, and time to vaccination
6 and 12 months

Secondary Outcomes (3)

Rates of new patients to the clinic (n of new patients/n of established patients)
6 and 12 months
Rate of use of other SBHC services (primary care visits, wellness assessments) (n of patients with primary care visits/n of new and established patients)
6 and 12 months
Rate of vaccination for other adolescent vaccinations (COVID-19, flu, Meningitis, or uptick of other vax's (TDAP, MMR, etc.)) (n of patients with additional vaccination among new and eligible clinic patients)
6 and 12 months

Study Arms (2)

Control time (pre-implementation)

NO INTERVENTION

All participating SBHCs offer routine HPV vaccination recommendations as part of clinical care and SBHC staff will continue to follow standard procedures to deliver these services. Further, all SBHCs have existing relationships with the affiliated schools, so the delivery of these healthcare services in the context of schools will not deviate from usual care.

Intervention (post-implementation)

EXPERIMENTAL

Intervention components (mailers, provider materials, and peer-to-peer educational sessions) will be administered during the intervention portion of each cluster.

Behavioral: MailersBehavioral: Provider MaterialsBehavioral: Peer-to-Peer Educational Sessions

Interventions

MailersBehavioral

Letter and fact sheet (infographic) mailed to caregivers of 9-14 year-olds and to teens 15-18, with optional phone call for "confidential patients" aged 15-18.

Intervention (post-implementation)

Provider MaterialsBehavioral

Clinic team/staff training based on qualitative interviews, recommended strategies and evidence-based interventions. Training materials include FAQs and Smart phrases. FAQs and informational sheets containing the same content as the mailers distributed in clinic to teen SBHC patients and their caregivers.

Study Design

Study Type

interventional

Phase

not applicable

Allocation

RANDOMIZED

Masking

NONE

Purpose

PREVENTION

Intervention Model

CROSSOVER

Model Details: The PEER study is a concurrent stepped wedge and patient randomized trial that will take place in 9 School Based Health Centers (SBHCs) in Oregon serviced by Multnomah County Health Department (MC) clinics. All clusters start in control and cross over in a randomized, staggered fashion, with all eventually receiving the intervention.

Sponsor Type

OTHER

Responsible Party

SPONSOR

Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (2)

Control time (pre-implementation)

Intervention (post-implementation)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (2)

Control time (pre-implementation)

Intervention (post-implementation)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations